These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21534887)

  • 1. Medical treatment of glaucoma: present and future.
    Fogagnolo P; Rossetti L
    Expert Opin Investig Drugs; 2011 Jul; 20(7):947-59. PubMed ID: 21534887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging drugs for ocular hypertension.
    Lee AJ; Goldberg I
    Expert Opin Emerg Drugs; 2011 Mar; 16(1):137-61. PubMed ID: 21352074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
    Stewart WC; Konstas AG; Nelson LA; Kruft B
    Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma.
    Prasanna G; Carreiro S; Anderson S; Gukasyan H; Sartnurak S; Younis H; Gale D; Xiang C; Wells P; Dinh D; Almaden C; Fortner J; Toris C; Niesman M; Lafontaine J; Krauss A
    Exp Eye Res; 2011 Sep; 93(3):256-64. PubMed ID: 21376717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pleiotropic effects in local drug treatment for glaucoma].
    Erb C
    Klin Monbl Augenheilkd; 2013 Feb; 230(2):141-5. PubMed ID: 23430678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Travoprost/timolol fixed combination in the management of open-angle glaucoma: a clinical review.
    Denis P
    Expert Opin Pharmacother; 2011 Feb; 12(3):463-71. PubMed ID: 21254951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroprotection and vasoprotection in glaucoma].
    Ignat F
    Oftalmologia; 2004; 48(2):5-14. PubMed ID: 15341092
    [No Abstract]   [Full Text] [Related]  

  • 8. [Glaucoma--strategy of treatment].
    Stefan C; Selaru D; Stefaniu I; Dumitrică DM
    Oftalmologia; 2008; 52(3):3-6. PubMed ID: 19149110
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mode of action, clinical profile and significance of beta-blockers in antiglaucoma therapy].
    Schlote T
    Klin Monbl Augenheilkd; 2013 Feb; 230(2):120-6. PubMed ID: 23430677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination therapy in the medical treatment of glaucoma].
    Hommer A
    Klin Monbl Augenheilkd; 2013 Feb; 230(2):133-40. PubMed ID: 23335083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraocular pressure lowering effect of dorzolamide/timolol fixed combination in patients with glaucoma who were unresponsive to prostaglandin analogs/prostamides.
    Martínez A; Sánchez M
    Curr Med Res Opin; 2007 Mar; 23(3):595-9. PubMed ID: 17355740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel inhibitors for the treatment of glaucoma.
    Cholkar K; Trinh HM; Pal D; Mitra AK
    Expert Opin Drug Discov; 2015 Mar; 10(3):293-313. PubMed ID: 25575654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study.
    Katz LJ; Rauchman SH; Cottingham AJ; Simmons ST; Williams JM; Schiffman RM; Hollander DA
    Curr Med Res Opin; 2012 May; 28(5):781-8. PubMed ID: 22458918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tafluprost for glaucoma.
    Papadia M; Bagnis A; Scotto R; Traverso CE
    Expert Opin Pharmacother; 2011 Oct; 12(15):2393-401. PubMed ID: 21916788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular hypotensive medications for the treatment of glaucoma.
    Lee DA
    Ophthalmol Clin North Am; 2005 Dec; 18(4):529-38. PubMed ID: 16314217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IOP-lowering efficacy and tolerability of preservative-free tafluprost 0.0015% among patients with ocular hypertension or glaucoma.
    Hommer A; Mohammed Ramez O; Burchert M; Kimmich F
    Curr Med Res Opin; 2010 Aug; 26(8):1905-13. PubMed ID: 20553122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the use of latanoprost for glaucoma since its launch.
    Digiuni M; Fogagnolo P; Rossetti L
    Expert Opin Pharmacother; 2012 Apr; 13(5):723-45. PubMed ID: 22348427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure.
    Shin DH; Feldman RM; Sheu WP;
    Ophthalmology; 2004 Feb; 111(2):276-82. PubMed ID: 15019375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
    Orzalesi N; Rossetti L; Bottoli A; Fogagnolo P
    Ophthalmology; 2006 Feb; 113(2):239-46. PubMed ID: 16458092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers to glaucoma drug delivery.
    Ghate D; Edelhauser HF
    J Glaucoma; 2008 Mar; 17(2):147-56. PubMed ID: 18344762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.